The Calmer Co International Limited (ASX:CCO)

Australia · Delayed Price · Currency is AUD

0.0030

+0.0010 (50.00%)

Jul 16, 2026, 9:59 AM AEST

Market Cap	10.56M +31.5%
Revenue (ttm)	8.10M +12.5%
Net Income	-3.37M
EPS	-0.00
Shares Out	3.52B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,719
Open	0.0030
Previous Close	0.0020
Day's Range	0.0030 - 0.0030
52-Week Range	0.0010 - 0.0050
Beta	0.66
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About ASX:CCO

The Calmer Co International Limited operates as a health and wellness company in Australia, Fiji, New Zealand, the United States, and internationally. It produces and sells powdered drinking kava, teas, and capsules under the FijiKava brand name; flavoured and non-flavoured kava shots, tinctures, and traditional and instant drinking kava under the Taki Mai brand name; hemp, CBD oils, topical salves, and pet CBD oils under Danodan brand name. In addition, it sells its products through retailers and online. The company was formerly known as Fiji ... [Read more]

Industry Packaged Foods

Sector Consumer Staples

Founded 2014

Country Australia

Stock Exchange Australian Securities Exchange

Ticker Symbol CCO

Full Company Profile

Financial Performance

In fiscal year 2025, ASX:CCO's revenue was 8.03 million, an increase of 88.48% compared to the previous year's 4.26 million. Losses were -3.99 million, 7.13% more than in 2024.

Financial Statements